Home | Breaking Out | AI powered stock trade ideas | Bullish Engulfing | Market Signals | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

Recently Featured Stock Charts
86% AI Stock Prediction Accuracy
Enter Stock Symbol to View AI powered Stock Chart

StockChartsAI.com

All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.


Stock Charts AI Power Rank: 7.0
Power Rank trending -> DOWN

Last Price: 137 - Change: 3.6 - Change %: 2.6987
06/24/2024 16:05:00 EST

Moderna Inc (MRNA)

Industry: Biotechnology

Price Support Resistance

In the past 20 trading days, MRNA has been trading in a range between $166.61 and $133.27 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

The AI powered stock chart is in a Yellow zone which means the stock is transitioning zones. We would avoid this stock currently.

Upside / Downside Potential

Moderna Inc $MRNA entered a Yellow zone 1 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $167.65, a potential upside of 22.37% from the recent price of 137.00. The stock is trading 24.43% (potential upside) below its 52 week high of $170.47 and 119.02 % (potential downside) above its 52 week low of $62.55 - based on the recent price.

Company Summary

Moderna, Inc, a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

MRNA Website

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
NEW YORK, June 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Source: PRNewsWire
Mon, 24 Jun 2024 18:52:00 -0400
Sentiment: Neutral
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, NY / ACCESSWIRE / June 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Moderna, Inc. ("Moderna" or "the Company") (NASDAQ:MRNA). Investors who purchased Moderna securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MRNA.
Source: Accesswire
Tue, 18 Jun 2024 11:00:00 -0400
Sentiment: Neutral
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.
Source: Zacks Investment Research
Mon, 17 Jun 2024 18:56:45 -0400
Sentiment: Neutral
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
Biotechnology firm Moderna Inc. NASDAQ: MNRA made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA (mRNA) technology for the development of innovative treatments.
Source: MarketBeat
Mon, 17 Jun 2024 07:41:23 -0400
Sentiment: Positive
Moderna Just Gave Investors Another Reason to Buy the Stock
Moderna's combination vaccine delivered positive news from the clinic. It is yet another win for Moderna's innovative mRNA-based approach.
Source: The Motley Fool
Sun, 16 Jun 2024 09:45:00 -0400
Sentiment: Positive
Instituions Institution %: 73.422
Last QTR Institution change: 6963703

Insiders
Insiders %: 9.576
Insiders Purchases last QTR: 0
Insiders Sales last QTR: 411255
Insiders Net last QTR: -411255

Analyst Ratings
Target Price: 167.65
Overall Rating: 3.56
Strong Buys (5): 7
Buys (4): 5
Holds (3): 10
Sells (2): 1
Strong Sells (1): 2

Technicals
52 Week Hi: 170.47
52 Week Low: 62.55
Beta: 1.54
50 Day MA: 130.5226
200 Day MA: 103.4849

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.851
Qtr Revenue Growth YOY: -0.91
Forward PE: 32.4675
Trailing PE: 0

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!

1000

Stock Analyzed Each Night

Portfolio

Easily Upload Track Your Stocks

Trends

See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.